- Advertisement -
London: Drugmaker Pfizer has signed a deal with a UN-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
In a statement, Pfizer said it would grant a licence for the…
